PTJ
SLXP

Paul Tudor Jones’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Paul Tudor Jones’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-50,400
Closed -$5.79M – 1770
2014
Q4 		$5.79M Buy
50,400
+37,771
+299% +$4.58M 0.2% 63
2014
Q3 		$1.97M Buy
12,629
+10,829
+602% +$1.57M 0.07% 131
2014
Q2 		$222K Sell
1,800
-5,600
-76% -$619K 0.01% 987
2014
Q1 		$767K Buy
7,400
+4,200
+131% +$430K 0.03% 299
2013
Q4 		$288K Sell
3,200
-5,200
-62% -$415K 0.01% 905
2013
Q3 		$562K Buy
8,400
+4,100
+95% +$283K 0.02% 294
2013
Q2 		$284K Buy
+4,300
New +$246K 0.02% 581

Other funds holding SLXP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Paul Tudor Jones's SLXP Position: Q1 2015 in Review

Paul Tudor Jones sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 50,400 shares — an estimated $5.79M sold.

Paul Tudor Jones first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $5.79M in Q4 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

  • Paul Tudor Jones reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
  • Paul Tudor Jones sold 50,400 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $5.79M.
  • Paul Tudor Jones first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
  • Paul Tudor Jones's SALIX PHARMACEUTICALS LTD DEL position peaked at $5.79M in Q4 2014.
  • 298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Tudor Investment Corp's 13F filing for Q1 2015, filed 15 May 2015.